Pain Management News

SAN DIEGO — The likelihood of opioid use among patients with autoimmune rheumatic disease has decreased annually by 15% since 2014, according to data presented at ACR Convergence 2023.

The FDA has advised consumers to exercise caution before using certain products promoted for arthritis and pain, as some have been found to contain hidden ingredients that may pose a significant health risk.

One in four adults relied solely on medications to manage chronic pain, highlighting an opportunity to increase use of nonpharmacologic therapies, particularly in men, older adults and those with public insurance, according to researchers.

Researchers identified multiple predictors of opioid overdose after an opioid prescription for chronic pain in a new study published in CMAJ.

Multiple diverse patient groups were less likely to have pain scores recorded or receive opioid or ketamine analgesia for pain compared with white patients, researchers found.

Screening for opioid use disorder, or OUD, in primary care clinics did not increase the percentage of new OUD diagnoses, according to results from a cluster randomized trial published in the Annals of Internal Medicine.

ORLANDO — A group of researchers at Ohio University Heritage College of Osteopathic Medicine created a cinematic virtual reality experience that conveys the human element of addiction.

ORLANDO — The CDC’s updated guidance on prescription opioids in 2022 were a step in the right direction, but nonopioid therapies should take a more “prominent role” in the management of pain, according to a speaker.

For patients with chronic pain, the right treatment could help prevent suicide, according to Kathleen M. Farrell, DO.

CDC data show that 16.2% of pregnant women aged 18 to 44 years reported using marijuana nearly every day.